Meitheal Pharmaceuticals said it has acquired the North American rights to a novel antibiotic for treating complicated urinary tract infections. The company said yesterday it's buying Contepo ...

“The escalating public health issue of antimicrobial resistance and emergence of highly resistant organisms demands immediate attention and innovative therapeutic solutions. The approval of CONTEPO is ...

Meitheal, a fully integrated biopharmaceutical company based in Chicago and focused on the development and commercialization of generic injectables, fertility, biologic and branded products, today ...